Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AMRI | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

4Q Revenues: $47.2 million (+1%)

4Q Loss: $844,000 (loss of $764,000 in 4Q2006)

FY Revenues: $192.5 million (+7%)

FY Earnings: $8.9 million (earnings were $2.2 million FY2006)

Comments: Total contract and milestone revenue for the quarter was $41.1 million (+2%) and for the year was $165.5 million (+8%). Milestone revenue for the year was $2.1 million, which includes $1.5 million resulting from the company’s collaborative research agreement with Bristol-Myers Squibb. Development/small scale manufacturing revenue was $11.4 million (+22%) in the quarter and $45.4 million (+26%) for the year. Discovery services revenue was $11.5 million (-6%) in the quarter and $41.6 million (+5%) for the year. Large scale manufacturing revenue for the quarter was $17.7 million (-6%) and for the year was $76.3 million (-1%). Recurring royalties from Allegra in quarter were $6.1 million (-4%) and for the year were flat at $27.1 million. FY results include large scale manufacturing restructuring charges of $177,000.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters